30 g, 15 g
Active Ingredient (s) & Strength
- Betamethasone (as Betamethasone valerate) 0.1%.
Indication
- ● Anti – inflammatory.
- ● Anti – pruritic.
- ● Vasoconstrictive.
Category: Products
Amrox Liquid
100 ml
Active Ingredient (s) & Strength
- Ambroxol hydrochloride 0.3%.
Indications
- Secretolytic Therapy in acute and Chronic bronchopulmonary
diseases associated with abnormal mucus secretion and
impaired Mucus transport.
Killy-Lice Shampoo
80 ml, 100 ml
Active Ingredient (s) & Strength
- Piperonyl butoxide 1.65%, Pyrethrum extract 0.165%.
Indications
- effective and safe one step treatment to Eliminate lice
infestation of the head and body.
Emacort Topical Solution
30 ml
Active Ingredient (s) & Strength
- ● Salicylic acid 2.0 %.
- ● Dexamethasone 0.12 %.
Indications
- ● Anti – inflammatory.
- ● Anti – allergic.
- ● Stimulates Stratum corneum (horny layer) and loosens scales.
Jofamin syrup
120 ml
Active Ingredient (s) & Strength
- Chlorpheniramine maleate 0.05%.
Indications
- ● Anti – histamine.
- ● Anti- allergic.
- ● Anti-pruritic.
Jofen Oral Drops
25 ml, 50 ml
Active Ingredient (s) & Strength
- Ibuprofen 4.0%.
Indications
- ● Reduce fever.
- ● relieves minor aches and pains due to
the common cold, flu, headaches and toothaches.
Dermoheal Cream
75 g
Active Ingredient (s) & Strength
- Urea 10%.
Indication
- ● High potency moisturizing cream.
- ● Moisturizer for dry and cracked skin on extremities like feet, lower legs, hands and elbow.
Free breath solution
20 ml
Active Ingredient (s) & Strength
- NaCl 0.71%.
Indications
- Free breath helps you clean your babies or childs nose
in depth in a gentle and soothing manner.
Bald X Topical Solution 5%
50 ml
Active Ingredient (s) & Strength
- Minoxidil 5.0 %.
Indications
- ● Stimulate hair growth.
- ● prevent hair loss.
Joxane
Active Ingredient (s): Enoxaparin Sodium Injection.
Strength: 4000 anti-Xa IU/0.4ml
Indications
- ● Prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery.
- ● Prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient.
- ● Treatment of deep vein thrombosis (DVT), complicated or uncomplicated by pulmonary embolism.
- ● Treatment of unstable angina and non-Q-wave myocardial infarction, in combination with acetylsalicylic acid (ASA).
- ● Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty
- ● Blood clot prevention in the extracorporeal circulation during haemodialysis.